White House Highlights UT Austin's Opioid Overdose Prevention Efforts

An image of the White House with "The White House Washington" written underneath.
March 13, 2024
The White House highlighted The University of Texas at Austin's pioneering opioid overdose prevention efforts through Operation Naloxone (now housed within UT's SHIFT initiatives) and the College of Pharmacy's PhARM Program in the Biden-Harris Administration's fact sheet for its challenge to save lives from overdose.

Texas Pharmacy Exceeds Residency Match Placement Goals

91% Residency Match Placement. National Average: 82%. The University of Texas at Austin College of Pharmacy. American Society of Health-System Pharmacists, 2023 Pharmacy Residency Match.
May 4, 2023
The University of Texas at Austin College of Pharmacy placed in the top ten in the entire country in the percentage of match placements with 91%, compared to the national match placement average of 82%.

FDA Considers Making Narcan Opioid Overdose Antidote Available Without Prescription

Two hands cradling a nasal spray dispenser for naloxone.
February 15, 2023
Clinical Associate Professor in the Division of Pharmacotherapy Dr. Kirk Evoy spoke to CNN about the possibilities of making naloxone, a medication used to reverse or reduce the effects of opioids, available over-the-counter.

Student Pharmacists Earn AAPP Foundation Grants

American Association of Psychiatric Pharmacists (AAPP) Collegiate Chapter.
February 9, 2023
Four Texas Pharmacy Pharm.D. students have earned recent grants and recognition by the American Association of Psychiatric Pharmacists (AAPP) Foundation.

Pharmacists: The Most Accessible Healthcare Provider, Unless You Have a Substance Use Disorder

White pill bottle with white pills on a black background.
August 23, 2022
P4 students, Megan Yeung, Kami Johnston and Morgan Murchison co-author a peer-reviewed blog in Pulses encouraging educators to adapt to reflect the specific needs of people who use drugs and patients with substance use disorders. This blog also highlights UT Pharmacy as a U.S. leader in substance use disorder and harm reduction education for Pharm.D. students.

Fewer Than Half of U.S. Pharmacies Carry One of the Most Effective Drugs for Opioid Abuse

A pharmacist holding a box of medication.
June 13, 2022
Tara Law from Time writes about how few pharmacies carry buprenorphine, a life-saving drug to help treat opioid use disorder (OUD). Lucas Hill, Pharm.D., BCACP, director of the college's Pharmacy Addictions Research & Medicine (PhARM) program, offers his insight on the issue, and how the DEA's crackdown of the drug puts OUD patients at risk.

UT Pharmacy Earns Highest Residency Match Rate in Texas

#1 Residency Match Placement in Texas
April 19, 2022
Pharmacy schools across the country completed their 2022 Phase I and Phase II residency matches for new or upcoming graduates of their Doctor of Pharmacy (Pharm.D.) programs. The University of Texas at Austin College of Pharmacy placed in the top ten of all pharmacy schools in the nation, and number one in Texas.

Commencement 2022

Three woman in doctorate regalia holding diplomas.
March 30, 2022
The College of Pharmacy's Convocation Ceremony will be Friday, May 20, 2022. Find more information on the college's Commencement 2022 page.

Opioid Use Disorder Paper Earns ACCP Award

A box of naloxone vials.
October 8, 2021
A paper from UT College of Pharmacy researchers was awarded the 2021 Outstanding Paper of the Year from the American College of Clinical Pharmacy (ACCP) Ambulatory Care Practice Research Network. The paper investigates the availability of buprenorphine and naloxone in Texas to treat opioid use disorder.

Immunologic Resilience: A New Metric to Accurately Gauge COVID-19’s Path

The COVID-19 virus.
September 8, 2021
UT Pharmacy and UT Health Science Center San Antonio Assistant Professor Grace C. Lee, Pharm.D., Ph.D. is the first author of a recently published study that unveiled a novel concept, “immunologic resilience,” to accurately predict which COVID-19 patients will advance to severe disease and which will not.